Agenus, Inc. (AGEN)
7.655
+0.12
(+1.53%)
USD |
NASDAQ |
Oct 09, 16:00
7.655
0.00 (0.00%)
After-Hours: 20:00
Agenus 30-Day Average Daily Volume : 1.082M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.082M |
| October 07, 2026 | 1.067M |
| October 06, 2026 | 1.068M |
| October 05, 2026 | 1.043M |
| October 02, 2026 | 1.062M |
| October 01, 2026 | 1.078M |
| September 30, 2026 | 1.090M |
| September 29, 2026 | 1.076M |
| September 28, 2026 | 1.054M |
| September 25, 2026 | 1.003M |
| September 24, 2026 | 1.002M |
| September 23, 2026 | 1.019M |
| September 22, 2026 | 1.045M |
| September 21, 2026 | 1.076M |
| September 18, 2026 | 1.072M |
| September 17, 2026 | 1.084M |
| September 16, 2026 | 1.107M |
| September 15, 2026 | 1.152M |
| September 14, 2026 | 1.181M |
| September 11, 2026 | 1.208M |
| September 10, 2026 | 1.282M |
| September 09, 2026 | 1.314M |
| September 08, 2026 | 1.359M |
| September 04, 2026 | 1.360M |
| September 03, 2026 | 1.368M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.422M |
| September 01, 2026 | 1.456M |
| August 31, 2026 | 1.520M |
| August 28, 2026 | 1.562M |
| August 27, 2026 | 1.596M |
| August 26, 2026 | 1.659M |
| August 25, 2026 | 1.783M |
| August 24, 2026 | 2.114M |
| August 21, 2026 | 7.897M |
| August 20, 2026 | 7.875M |
| August 19, 2026 | 7.844M |
| August 18, 2026 | 7.794M |
| August 17, 2026 | 7.801M |
| August 14, 2026 | 7.791M |
| August 13, 2026 | 7.772M |
| August 12, 2026 | 7.773M |
| August 11, 2026 | 7.756M |
| August 10, 2026 | 7.742M |
| August 07, 2026 | 7.845M |
| August 06, 2026 | 7.825M |
| August 05, 2026 | 7.764M |
| August 04, 2026 | 7.730M |
| August 03, 2026 | 7.679M |
| July 31, 2026 | 7.653M |
| July 30, 2026 | 7.624M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Halozyme Therapeutics, Inc. | 2.272M |
| Novavax, Inc. | 6.764M |
| AVITA Medical, Inc. | 306854.3 |
| Iovance Biotherapeutics, Inc. | 16.33M |
| Amgen, Inc. | 2.956M |